PRODUCT DETAILS

About Albetis Oral Suspension Pineapple

ALBENDAZOLE+IVERMECTIN belongs to the class of medications called ‘antihelmintic’ used to treat parasitic worm infections. Parasitic worm infections are intestinal worm infections that are caused by the ingestion of contaminated food and water. ALBENDAZOLE+IVERMECTIN can be used to treat infections caused by roundworms, hookworms, threadworm, whipworm, pinworm, flukes, and other parasites. 

Uses of Albetis Oral Suspension Pineapple

Parasitic worm infections

Medicinal Benefits of Albetis Oral Suspension Pineapple

ALBENDAZOLE+IVERMECTIN contains ‘Albendazole’ and ‘Ivermectin’ which belongs to the class of medications called ‘antihelmintic’. It is a broad-spectrum antibiotic used in the treatment of parasitic infections. It can kill the disease-causing worms and stop the spread of infection effectively. Albendazole interrupts the absorption of glucose by the worm leading to energy depletion. Ivermectin acts by paralyzing the worms, consequently leading them to death.

Directions for Use

ALBENDAZOLE+IVERMECTIN is available in the following dosage forms: tablet and suspension Oral tablet: It is advised to swallow the tablet as a whole with water, so do not crush, break, or chew it. The dose of the medicine is determined by your doctor based on your condition. 0ral suspension: Shake the bottle well before each use. Take the prescribed dose of medicine with a marked measuring spoon, oral syringe, or medicine cup, followed by water. It may cause a bitter or metallic taste, so avoid taking it at the same time as food or other drinks.

Side Effects of Albetis Oral Suspension Pineapple

• Stomach pain
• Nausea
• Vomiting
• Headache
• Dizziness
• Decrease in white blood cell count (leucopenia)
• Vision problems
• Confusion
• Weakness
  • Difficulty walkin

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug Warnings

ALBENDAZOLE+IVERMECTIN may cause suppression of the bone marrow and cause anemia. Inform your doctor if you have/had liver disease; if you have any surgery, including dental surgery. Consult your doctor immediately if you experience seizures, extreme tiredness, behavior changes, blurred vision, trouble walking, or neck pain while taking ALBENDAZOLE+IVERMECTIN. Consult your doctor if you notice unusual bleeding or bruising as you may bleed or bruise easily while taking ALBENDAZOLE+IVERMECTIN. It may cause orthostatic hypotension (dizziness upon rising up quickly), so avoid standing up too quickly from a sitting or lying position

Drug Interactions

Drug-Drug Interaction:

ALBENDAZOLE+IVERMECTIN may interact with sedatives (phenobarbital and butalbital), anti-anxiety drugs (clonazepam, clozapine, and lorazepam), narcotic (sodium oxybate), a medication used to treat epilepsy (valproic acid), anthelmintic (praziquantel), corticosteroid (dexamethasone), antacid (cimetidine), anti-asthma (theophylline),

Drug-Disease Interaction:

ALBENDAZOLE+IVERMECTIN should be used with caution in patients with myelosuppression (bone marrow suppression), hepatobiliary dysfunction (liver and biliary disease), neurological disorder, meningitis (inflammation of the membranes of brain), sleeping sickness, HIV, and kidney dysfunction

Safety Advice

ALCOHOL

ALBENDAZOLE+IVERMECTIN may interact with alcohol and worsen the condition.

PREGNANCY

ALBENDAZOLE+IVERMECTIN is a category C drug and may cause toxic effects to the unborn baby. So, your doctor may prescribe this medicine if the benefits outweigh the risks.

BREAST FEEDING

• ALBENDAZOLE+IVERMECTIN may get excreted in the breast milk. So, your doctor may advise you to stop breastfeeding while taking this medicine.

DRIVING

ALBENDAZOLE+IVERMECTIN may cause dizziness and vision problems, so refrain from driving or operating heavy machinery while using this medicine.

LIVER

ALBENDAZOLE+IVERMECTIN should be used with caution in patients with liver diseases. Dose adjustments may be necessary.

KIDNEY

ALBENDAZOLE+IVERMECTIN should be used with caution in patients with kidney diseases. Dose adjustments may be necessary.